0000950170-23-071885.txt : 20231220
0000950170-23-071885.hdr.sgml : 20231220
20231220160854
ACCESSION NUMBER: 0000950170-23-071885
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231219
FILED AS OF DATE: 20231220
DATE AS OF CHANGE: 20231220
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kavuru Vimal
CENTRAL INDEX KEY: 0001697184
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35776
FILM NUMBER: 231501425
MAIL ADDRESS:
STREET 1: 11 MAACKA DRIVE
CITY: HOLMDEL
STATE: NJ
ZIP: 07733
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Acasti Pharma Inc.
CENTRAL INDEX KEY: 0001444192
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: A8
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 103 CARNEGIE CENTER
STREET 2: SUITE 300
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 609-649-9272
MAIL ADDRESS:
STREET 1: 103 CARNEGIE CENTER
STREET 2: SUITE 300
CITY: PRINCETON
STATE: NJ
ZIP: 08540
4
1
ownership.xml
4
X0508
4
2023-12-19
0001444192
Acasti Pharma Inc.
ACST
0001697184
Kavuru Vimal
103 CARNEGIE CENTER
SUITE 300
PRINCETON
NJ
08540
true
false
true
false
false
Stock Options (Right to Buy)
2.125
2023-12-19
4
A
false
10000
0
A
2033-12-19
Class A Common Shares
10000
10000
D
Stock options granted on 12/19/2023 under the Acasti Pharma Stock Option Plan, which vest in equal monthly installments over a period of 12 months, provided that 3/12 of the options shall be deemed to have vested upon the date of grant.
/s/ Vimal Kavuru
2023-12-20